Cephalon subpoenaed by post office regarding Fentora | Philadelphia Business Journal: "Cephalon Inc. disclosed Friday in a filing with the Securities and Exchange Commission that it received a subpoena from the U.S. Postal Service Office of Inspector General seeking information about Fentora, the company’s drug approved to treat severe pain in cancer patients."
No comments:
Post a Comment